Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: A Phase I trial

Seminars in Oncology

Volumn 24, Issue 1 SUPPL. 2, 1997, Pages

  Meerpohl, H G ^a   Du Bois, A ^a   Luck, H J ^a   Kuhnle, H ^a   Mobus, V ^a   Kreienberg, R ^a   Bauknecht, T ^a   Kochli, O ^a   Bochtler, H ^a   Diergarten, K ^a  

^a St Vincentius Krankenhauser   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CLEMASTINE; DEXAMETHASONE; PACLITAXEL;

ADVANCED CANCER; AREA UNDER THE CURVE; ARTHRALGIA; BONE MARROW TOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAXIMUM ALLOWABLE CONCENTRATION; ORAL DRUG ADMINISTRATION; OVARY CANCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; NEUTROPENIA; OVARIAN NEOPLASMS; PACLITAXEL; THROMBOCYTOPENIA;

EID: 0031055588     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)